20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

NCT01568216 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
121
Enrollment
INDUSTRY
Sponsor class

Stopped Toxic Epidermal Necrolysis

Conditions

Interventions

Sponsor

Amgen